Cargando…
The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
BACKGROUND: COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the S...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031186/ https://www.ncbi.nlm.nih.gov/pubmed/36949421 http://dx.doi.org/10.1186/s12889-023-15294-7 |
_version_ | 1784910549593620480 |
---|---|
author | Zhang, Xi-Ru Li, Zhi-Ju Fu, Qi Wang, Jin-Dong Huang, Qing-Mei Song, Wei-Qi Xu, Xiao-Yu Li, Zhi-Hao Mao, Chen |
author_facet | Zhang, Xi-Ru Li, Zhi-Ju Fu, Qi Wang, Jin-Dong Huang, Qing-Mei Song, Wei-Qi Xu, Xiao-Yu Li, Zhi-Hao Mao, Chen |
author_sort | Zhang, Xi-Ru |
collection | PubMed |
description | BACKGROUND: COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness. METHODS: A cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated. RESULTS: Among 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated. CONCLUSION: Although the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15294-7. |
format | Online Article Text |
id | pubmed-10031186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100311862023-03-22 The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China Zhang, Xi-Ru Li, Zhi-Ju Fu, Qi Wang, Jin-Dong Huang, Qing-Mei Song, Wei-Qi Xu, Xiao-Yu Li, Zhi-Hao Mao, Chen BMC Public Health Research BACKGROUND: COVID-19, which is caused by SARS-CoV-2, is a major global health threat. The dominant variant of SARS-CoV-2 has changed over time due to continuous evolution. We aimed to evaluate the coverage of SARS-CoV-2 vaccination among employees in China, explore their willingness to receive the SARS-CoV-2 variant vaccine and examine the potential factors influencing vaccination coverage and willingness. METHODS: A cross-sectional epidemiological survey was conducted online from January 1, 2022, to January 30, 2022. The information collected in the survey included sociodemographic characteristics, lifestyle habits, vaccination coverage, willingness to be vaccinated against SARS-CoV-2 variants and the reasons for vaccination and willingness. Multivariable logistic regression models were used to assess the associations of potential factors with the rate of vaccination and the willingness to be vaccinated. RESULTS: Among 62,395 eligible participants, the coverage of SARS-CoV-2 vaccination was 98.9% for at least one dose and 70.1% for a booster. The great majority of vaccinated individuals (94.4%) voluntarily received the vaccine. A total of 60,694 respondents (97.7%) were willing to be vaccinated against SARS-CoV-2 variants, mainly due to confidence in the effectiveness of vaccines (92.8%). A total of 1431 respondents were unwilling to be vaccinated, mainly because of concerns about the adverse effects of vaccines (77.6%). Longer education duration was associated with a higher rate of SARS-CoV-2 vaccination and willingness to be vaccinated. General or poor health status and having no history of influenza vaccination were associated with a lower rate of SARS-CoV-2 vaccination and willingness to be vaccinated. Additionally, we observed a significant positive association of abuse experience with the willingness to be vaccinated. CONCLUSION: Although the rate of SARS-CoV-2 vaccination and the willingness to be vaccinated were relatively high in the study population, there were still some respondents with vaccine hesitancy. Relevant strategies based on significant related factors should be developed and implemented to encourage vaccination. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-023-15294-7. BioMed Central 2023-03-22 /pmc/articles/PMC10031186/ /pubmed/36949421 http://dx.doi.org/10.1186/s12889-023-15294-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhang, Xi-Ru Li, Zhi-Ju Fu, Qi Wang, Jin-Dong Huang, Qing-Mei Song, Wei-Qi Xu, Xiao-Yu Li, Zhi-Hao Mao, Chen The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China |
title | The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China |
title_full | The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China |
title_fullStr | The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China |
title_full_unstemmed | The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China |
title_short | The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China |
title_sort | coverage of sars-cov-2 vaccination and the willingness to receive the sars-cov-2 variant vaccine among employees in china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031186/ https://www.ncbi.nlm.nih.gov/pubmed/36949421 http://dx.doi.org/10.1186/s12889-023-15294-7 |
work_keys_str_mv | AT zhangxiru thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT lizhiju thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT fuqi thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT wangjindong thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT huangqingmei thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT songweiqi thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT xuxiaoyu thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT lizhihao thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT maochen thecoverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT zhangxiru coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT lizhiju coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT fuqi coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT wangjindong coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT huangqingmei coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT songweiqi coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT xuxiaoyu coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT lizhihao coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina AT maochen coverageofsarscov2vaccinationandthewillingnesstoreceivethesarscov2variantvaccineamongemployeesinchina |